Losapotatab1 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 01)
Losortan Potassium
Product Images NDC 53002-7624
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losortan Potassium (NDC 53002-7624). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Losapotatab2 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 02)
Losapotatab3 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 03)
This text provides information about a study involving Atenolol and Losartan Potassium in patients with a history of stroke. The adjusted risk reduction for fatal/non-fatal stroke was 25%, with a p-value of 0.001. The study was conducted over a period of 66 months.*
Losapotatab (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 04)
Losapotatab5 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 05)
This text appears to be related to a study or analysis involving patients and events. It mentions the number of patients and the percentage of risk reduction (16.1%) associated with a certain variable. Additionally, there is a reference to "Losartan Potassium Tablet" and "Placebo". The significance level of the observation is indicated by "p=0.022". However, the last line of text is not clear and readable, making it difficult to provide a complete description.*
Label Image (Lbl530027624)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
